Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors.

Bielle F, Fréneaux P, Jeanne-Pasquier C, Maran-Gonzalez A, Rousseau A, Lamant L, Paris R, Pierron G, Nicolas AV, Sastre-Garau X, Delattre O, Bourdeaut F, Peuchmaur M.

Am J Surg Pathol. 2012 Aug;36(8):1141-9. doi: 10.1097/PAS.0b013e31825a6895.

PMID:
22790854
2.

A study of gata3 and phox2b expression in tumors of the autonomic nervous system.

Nonaka D, Wang BY, Edmondson D, Beckett E, Sun CC.

Am J Surg Pathol. 2013 Aug;37(8):1236-41. doi: 10.1097/PAS.0b013e318289c765.

PMID:
23715162
3.

Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.

Hata JL, Correa H, Krishnan C, Esbenshade AJ, Black JO, Chung DH, Mobley BC.

Arch Pathol Lab Med. 2015 Apr;139(4):543-6. doi: 10.5858/arpa.2014-0255-OA.

PMID:
25822764
4.

PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumors.

Hung YP, Lee JP, Bellizzi AM, Hornick JL.

Histopathology. 2017 Jun 22. doi: 10.1111/his.13288. [Epub ahead of print]

PMID:
28640941
5.

PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.

Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Kleijn I, Dee R, Hooft L, van Noesel MM, Bierings M, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA.

J Clin Oncol. 2008 Nov 20;26(33):5443-9. doi: 10.1200/JCO.2007.13.6531. Epub 2008 Oct 6.

PMID:
18838715
6.

Immunohistochemical expression of CRX in extracranial malignant small round cell tumors.

Terry J, Calicchio ML, Rodriguez-Galindo C, Perez-Atayde AR.

Am J Surg Pathol. 2012 Aug;36(8):1165-9. doi: 10.1097/PAS.0b013e3182601d84.

PMID:
22790857
7.

Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors.

Miettinen M, Chatten J, Paetau A, Stevenson A.

Am J Surg Pathol. 1998 Mar;22(3):327-32.

PMID:
9500774
8.

Prevalence and functional consequence of PHOX2B mutations in neuroblastoma.

Raabe EH, Laudenslager M, Winter C, Wasserman N, Cole K, LaQuaglia M, Maris DJ, Mosse YP, Maris JM.

Oncogene. 2008 Jan 17;27(4):469-76. Epub 2007 Jul 16.

PMID:
17637745
9.

NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.

Yoshida A, Sekine S, Tsuta K, Fukayama M, Furuta K, Tsuda H.

Am J Surg Pathol. 2012 Jul;36(7):993-9. doi: 10.1097/PAS.0b013e31824ee43c.

PMID:
22446943
10.

Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.

Wehrli BM, Huang W, De Crombrugghe B, Ayala AG, Czerniak B.

Hum Pathol. 2003 Mar;34(3):263-9.

PMID:
12673561
11.

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H.

Cancer. 2001 Nov 15;92(10):2699-708.

PMID:
11745206
12.

Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.

Wang NP, Marx J, McNutt MA, Rutledge JC, Gown AM.

Am J Pathol. 1995 Dec;147(6):1799-810.

14.

Diagnostic and prognostic information obtained on fine-needle aspirates of primary neuroblastic tumors: Proposal for a cytology prognostic score.

Klijanienko J, Couturier J, Brisse H, Pierron G, Fréneaux P, Berger F, Maciorowski Z, Sastre-Garau X, Michon J, Schleiermacher G.

Cancer Cytopathol. 2011 Dec 25;119(6):411-23. doi: 10.1002/cncy.20173. Epub 2011 Jul 19.

15.

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.

Cancer. 2004 Oct 15;101(8):1873-81.

16.

Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.

Krishnan C, Higgins JP, West RB, Natkunam Y, Heerema-McKenney A, Arber DA.

Am J Surg Pathol. 2009 Nov;33(11):1695-704. doi: 10.1097/PAS.0b013e3181b0ebdc.

PMID:
19701075
17.

Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.

Krona C, Carén H, Sjöberg RM, Sandstedt B, Laureys G, Kogner P, Martinsson T.

Int J Oncol. 2008 Mar;32(3):575-83.

PMID:
18292934
18.

Neuroectodermal and neuroendocrine tumors principally seen in children.

Parham DM.

Am J Clin Pathol. 2001 Jun;115 Suppl:S113-28. Review.

PMID:
11993686
19.

Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis.

Fagone P, Nicoletti F, Vecchio GM, Parenti R, Magro G.

Acta Histochem. 2015 Oct;117(8):820-3. doi: 10.1016/j.acthis.2015.10.002. Epub 2015 Oct 25.

PMID:
26510683
20.

The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.

de Torres C, Beleta H, Díaz R, Toran N, Rodríguez E, Lavarino C, García I, Acosta S, Suñol M, Mora J.

Cancer. 2009 Jun 15;115(12):2792-803. doi: 10.1002/cncr.24304.

Supplemental Content

Support Center